Sanjiv Patel, President and CEO at Relay Therapeutics, Inc. (RLAY), sold 123,412 shares at $9.16 ($1.1M) on 2024-07-25, disclosed to the SEC on 2024-07-29.
Scheduled sale ($1.1M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.16 | 50,000 | $458K | 40.8% |
| 2 | $9.07 | 36,706 | $333K | 29.6% |
| 3 | $9.07 | 36,706 | $333K | 29.6% |
| Total | $9.11 avg | 123,412 | $1.1M | 100% |
| Filing → |
| RLAY | SELL | 2026-08-18 | $980K | — | Filing → |
| RLAY | SELL | 2026-07-08 | $944K | — | Filing → |
| RLAY | SELL | 2026-01-07 | $338K | — | Filing → |